Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 358

Similar articles for PubMed (Select 17966038)

1.
2.

The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.

Wong FS, Visintin I, Wen L, Granata J, Flavell R, Janeway CA.

J Exp Med. 1998 Jun 15;187(12):1985-93.

3.

The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.

Wen L, Chen NY, Tang J, Sherwin R, Wong FS.

J Clin Invest. 2001 Apr;107(7):871-80.

4.

Expression of the B7.1 costimulatory molecule on pancreatic beta cells abrogates the requirement for CD4 T cells in the development of type 1 diabetes.

Havari E, Lennon-Dumenil AM, Klein L, Neely D, Taylor JA, McInerney MF, Wucherpfennig KW, Lipes MA.

J Immunol. 2004 Jul 15;173(2):787-96.

6.
7.

In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes.

Wen L, Wong FS, Tang J, Chen NY, Altieri M, David C, Flavell R, Sherwin R.

J Exp Med. 2000 Jan 3;191(1):97-104.

8.
9.
11.

Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.

Ye Z, Ahmed KA, Hao S, Zhang X, Xie Y, Munegowda MA, Meng Q, Chibbar R, Xiang J.

Autoimmunity. 2008 Nov;41(7):501-11. doi: 10.1080/08916930802069256.

PMID:
18855194
12.

The diabetogenic, insulin-specific CD8 T cell response primed in the experimental autoimmune diabetes model in RIP-B7.1 mice.

Karges W, Rajasalu T, Spyrantis A, Wieland A, Boehm B, Schirmbeck R.

Eur J Immunol. 2007 Aug;37(8):2097-103.

PMID:
17615584
13.
14.

Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent.

Pechhold K, Patterson NB, Blum C, Fleischacker CL, Boehm BO, Harlan DM.

J Immunol. 2001 Feb 15;166(4):2531-9.

15.

Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.

Ohashi PS, Oehen S, Aichele P, Pircher H, Odermatt B, Herrera P, Higuchi Y, Buerki K, Hengartner H, Zinkernagel RM.

J Immunol. 1993 Jun 1;150(11):5185-94.

PMID:
8496610
16.

Cytotoxic T cell-mediated diabetes in RIP-CD80 transgenic mice: autoantigen peptide sensitivity and fine specificity.

Pechhold K, Chakrabarty S, Harlan DM.

Ann N Y Acad Sci. 2007 Apr;1103:132-42. Epub 2007 Mar 21.

PMID:
17376836
17.

A CD8+ T-lymphocyte-mediated and CD4+ T-lymphocyte-independent autoimmune diabetes of early onset in transgenic mice.

Herrera PL, Harlan DM, Fossati L, Izui S, Huarte J, Orci L, Vassalli JD, Vassalli P.

Diabetologia. 1994 Dec;37(12):1277-9.

PMID:
7534735
19.

CD86 has sustained costimulatory effects on CD8 T cells.

Thomas IJ, Petrich de Marquesini LG, Ravanan R, Smith RM, Guerder S, Flavell RA, Wraith DC, Wen L, Wong FS.

J Immunol. 2007 Nov 1;179(9):5936-46.

20.

A 20-Mb region of chromosome 4 controls TNF-alpha-mediated CD8+ T cell aggression toward beta cells in type 1 diabetes.

Chamberlain G, Wållberg M, Rainbow D, Hunter K, Wicker LS, Green EA.

J Immunol. 2006 Oct 15;177(8):5105-14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk